Cosentyx receives expanded approvals in EU for use in childhood arthritic conditions
from PharmaTimes: News RSS https://ift.tt/iTJSdtM
Post Top Ad
Monday, 27 June 2022
EU approves Norvatis’ Cosentyx for childhood arthritis
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment